Articles with public access mandates - Keith A Johnson - Canadian Institutes of Health ResearchLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallDFGFWOSFIDSTFWFFNRSNIHGovernment of SpainGovernment of ItalyNSFCFCTEuropean CommissionSTFCAcademy of FinlandDOECSIRNSFNKFIBELSPOMESTDOTKAMTACASHelmholtzBMBFSNSFTUBITAKNCNCIHRDoDFAPESPMRCNHMRCNIHRSwedish Research CouncilARCNSERCHHMIWellcomeFRQSNWOUK Research & InnovationKnut and Alice Wallenberg FoundationGovernment of ArgentinaDFFDNRFNRFARRSRCNDoris Duke Charitable FoundationResearch Grants Council, Hong KongRoyal Society UKParkinson's Foundation, USAAHAGenome CanadaINSERMMarianne and Marcus Wallenberg FoundationAlzheimers's UKBBSRCEPSRCZonMwANRUSAIDHSFBanking Foundation "la Caixa"HRBCancer Research UKCanada First Research Excellence FundGatesFordNASAVAEMBLBHFDMTState of CalifoniaFRQNTNMRCMichael J Fox FoundationMQ Mental Health ResearchCZI
Available based on mandate: 68
Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies.
OL Hampton, S Mukherjee, MJ Properzi, AP Schultz, PK Crane, ...
Neuropsychology 37 (4), 436, 2023
Tau positron emission tomography in preclinical Alzheimer’s disease
PS Insel, CB Young, PS Aisen, KA Johnson, RA Sperling, EC Mormino, ...
Brain 146 (2), 700-711, 2023
APOE effects on regional tau in preclinical Alzheimer’s disease
CB Young, E Johns, G Kennedy, ME Belloy, PS Insel, MD Greicius, ...
Molecular neurodegeneration 18 (1), 1, 2023
Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment
C Strikwerda-Brown, DA Hobbs, J Gonneaud, F St-Onge, AP Binette, ...
JAMA neurology 79 (10), 975-985, 2022
Spatial extent of amyloid-β levels and associations with tau-PET and cognition
H Ozlen, AP Binette, T Köbe, PF Meyer, J Gonneaud, F St-Onge, ...
JAMA neurology 79 (10), 1025-1035, 2022
Association of β-amyloid and vascular risk on longitudinal patterns of brain atrophy
JS Rabin, J Pruzin, M Scott, HS Yang, O Hampton, S Hsieh, AP Schultz, ...
Neurology 99 (3), e270-e280, 2022
AT (N) predicts near-term development of Alzheimer’s disease symptoms in unimpaired older adults
C Strikwerda-Brown, J Gonneaud, DA Hobbs, F St-Onge, AP Binette, ...
medRxiv, 2022.05. 09.22274638, 2022
Tau‐atrophy variability reveals phenotypic heterogeneity in Alzheimer's disease
SR Das, X Lyu, MT Duong, L Xie, L McCollum, R de Flores, M DiCalogero, ...
Annals of neurology 90 (5), 751-762, 2021
Identifying sensitive measures of cognitive decline at different clinical stages of Alzheimer’s disease
RJ Jutten, SAM Sikkes, RE Amariglio, RF Buckley, MJ Properzi, ...
Journal of the International Neuropsychological Society 27 (5), 426-438, 2021
Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation
ME Farrell, S Jiang, AP Schultz, MJ Properzi, JC Price, JA Becker, ...
Neurology 96 (4), e619-e631, 2021
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
MA Dubbelman, RJ Jutten, SE Tomaszewski Farias, RE Amariglio, ...
Alzheimer's Research & Therapy 12, 1-11, 2020
Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults
JS Rabin, Z Shirzadi, W Swardfager, BJ MacIntosh, A Schultz, HS Yang, ...
Neurobiology of aging 93, 124-130, 2020
White matter atrophy in cerebral amyloid angiopathy
P Fotiadis, YD Reijmer, SJ Van Veluw, S Martinez-Ramirez, ...
Neurology 95 (5), e554-e562, 2020
Multiple markers contribute to risk of progression from normal to mild cognitive impairment
JS Rabin, TE Neal, HE Nierle, SAM Sikkes, RF Buckley, RE Amariglio, ...
NeuroImage: Clinical 28, 102400, 2020
Examining cognitive decline across black and white participants in the Harvard Aging Brain Study
RE Amariglio, RF Buckley, JS Rabin, KV Papp, YT Quiroz, EC Mormino, ...
Journal of Alzheimer's Disease 75 (4), 1437-1446, 2020
Blood-based protein mediators of senility with replications across biofluids and cohorts
DR Royall, RF Palmer, Alzheimer’s Disease Neuroimaging Initiative
Brain communications 2 (1), fcz036, 2020
Resting state BOLD variability is linked to white matter vascular burden in healthy aging but not in older adults with subjective cognitive decline
V Scarapicchia, M Garcia-Barrera, S MacDonald, JR Gawryluk
Frontiers in human neuroscience 13, 429, 2019
Using subjective cognitive decline to identify high global amyloid in community‐based samples: a cross‐cohort study
RF Buckley, S Sikkes, VL Villemagne, EC Mormino, JS Rabin, S Burnham, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (1 …, 2019
Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
OA Halawa, JR Gatchel, RE Amariglio, DM Rentz, RA Sperling, ...
Alzheimer's research & therapy 11, 1-10, 2019
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
KV Papp, R Buckley, E Mormino, P Maruff, VL Villemagne, CL Masters, ...
Alzheimer's & Dementia, 2019
Publication and funding information is determined automatically by a computer program